S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Biden Out, _______ In? (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
An Unusual Way to Invest in Gold (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Biden Out, _______ In? (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
An Unusual Way to Invest in Gold (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Biden Out, _______ In? (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
An Unusual Way to Invest in Gold (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Biden Out, _______ In? (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
An Unusual Way to Invest in Gold (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy

STERIS (STE) Stock Forecast & Price Target

$224.27
+4.01 (+1.82%)
(As of 02/9/2024 08:57 PM ET)

STERIS Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 5 Analyst Ratings

Analysts' Consensus Price Target

$239.60
6.84% Upside
High Forecast$265.00
Average Forecast$239.60
Low Forecast$215.00
TypeCurrent Forecast
2/12/23 to 2/12/24
1 Month Ago
1/13/23 to 1/13/24
3 Months Ago
11/14/22 to 11/14/23
1 Year Ago
2/12/22 to 2/12/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$239.60$240.60$242.60$234.50
Predicted Upside6.84% Upside12.48% Upside11.12% Upside14.85% Upside
Get STERIS Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.


STE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

STE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

STERIS Stock vs. The Competition

TypeSTERISMedical CompaniesS&P 500
Consensus Rating Score
2.60
2.67
2.48
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside6.84% Upside1,117.99% Upside8.84% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/9/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$250.00+12.64%
2/8/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Outperform ➝ Market Outperform$265.00+21.65%
2/6/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$253.00+15.05%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$225.00 ➝ $215.00+5.65%
10/26/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$220.00 ➝ $215.00+1.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 04:19 AM ET.












STE Price Target - Frequently Asked Questions

What is STERIS's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for STERIS stock is Moderate Buy based on the current 2 hold ratings and 3 buy ratings for STE. The average twelve-month price prediction for STERIS is $239.60 with a high price target of $265.00 and a low price target of $215.00. Learn more on STE's analyst rating history.

Do Wall Street analysts like STERIS more than its competitors?

Analysts like STERIS less than other Medical companies. The consensus rating score for STERIS is 2.60 while the average consensus rating score for medical companies is 2.67. Learn more on how STE compares to other companies.

Does STERIS's stock price have much upside?

According to analysts, STERIS's stock has a predicted upside of 11.51% based on their 12-month stock forecasts.

What analysts cover STERIS?

STERIS has been rated by JMP Securities, KeyCorp, Morgan Stanley, and Stephens in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:STE) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -